Eflornithine
Term · Oncology and biomedicine · MLC-T-ONC-013225
A difluoromethylated ornithine compound with antineoplastic activity. Eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme required for polyamine biosynthesis, thereby inhibiting the formation and proliferation of tumor cells. Polyamines are involved in nucleosome oligomerization and DNA conformation, creating a chromatin environment that stimulates neoplastic transformation of cells. This agent has been shown to induce apoptosis in leiomyoma cells.
| Identifier | MLC-T-ONC-013225 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | DFMO |
| Synonyms | alpha-difluoromethylornithine; difluoromethylornithine; difluromethylornithine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-013225",
"term": "Eflornithine",
"field": "Oncology and biomedicine",
"definition": "A difluoromethylated ornithine compound with antineoplastic activity. Eflornithine irreversibly inhibits ornithine decarboxylase, an enzyme required for polyamine biosynthesis, thereby inhibiting the formation and proliferation of tumor cells. Polyamines are involved in nucleosome oligomerization and DNA conformation, creating a chromatin environment that stimulates neoplastic transformation of cells. This agent has been shown to induce apoptosis in leiomyoma cells.",
"abbreviation": "DFMO",
"synonyms": [
"alpha-difluoromethylornithine",
"difluoromethylornithine",
"difluromethylornithine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/eflornithine/"
}
Record 6,405 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.